Previous Close | 30.42 |
1-Year Change | 174.05% |
6-Months Change | -21.84% |
3-Months Change | -19.88% |
Moving Avg (50d) | 34.313 |
Moving Avg (200d) | 33.416 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.07B |
Beta (3-Years) | 0.87 |
Revenue Growth (ttm) | 29.07% |
Net Profit Margin (ttm) | -12.44% |
Return On Assets (ttm) | -4.97% |
EPS (ttm) | -0.45 |
PE Ratio (ttm) | -67.6 |
Dividend Yield | % |
Asset Description: | Harrow Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
29.812 | 28.899 | 28.291 | 27.378 | 25.857 | 24.336 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |